TGFBI and corneal dystrophy: Importantly, the CRISPR/Cas9-mediated genome editing described here can now easily be adapted for the generation of additional TGFBI knockout clones in other cell lines, and future studies will be aimed at correcting the TGFBI gene mutations present in corneal dystrophy using advanced CRISPR/Cas9 systems.